Crescent Capital BDC: NAV Decline Continues Following Q1 Earnings

Crescent Capital BDC (CCAP) is exhibiting mixed performance, with a 14.6% price decline over the last year despite a high dividend yield of 12.5%. While CCAP now trades at a discount to NAV, making it potentially attractive to long-term investors, Q1 earnings revealed a decline in net investment income to $0.45 per share and an increase in non-accruals to 3.5% of cost, raising concerns about distribution coverage and the sustainability of its payouts amid a high interest rate environment; therefore, a hold rating is maintained.

Analysis

Crescent Capital BDC (CCAP) presents a challenging investment case, characterized by a significant 14.6% stock price decline over the past year and a negative 4.3% total return, despite an alluring 12.5% dividend yield. The company's shares trade at a 21.25% discount to its Net Asset Value (NAV) of $19.62 per share—wider than its 17.28% three-year average—reflecting deteriorating fundamentals. Q1 2025 results highlighted these issues, with net investment income (NII) declining to $0.45 per share and total investment income falling to $42.1 million from $50.3 million year-over-year. This downturn is significantly influenced by an increase in non-accrual loans, which rose to 3.5% of portfolio cost and 1.8% of fair value (from 2.2% and 0.9% respectively), leading to $6.5 million in net realized losses and a third consecutive quarterly drop in NAV. Although CCAP’s portfolio is defensively structured with 91% first-lien debt and 97% floating-rate assets, the persistent high-interest rate environment is visibly stressing borrowers; CCAP's 1.8% non-accrual rate at fair value is notably higher than peers like SLR Investment Corp. (0.6%). Consequently, dividend coverage has weakened from 131% to approximately 107% ($0.45 NII vs. $0.42 distribution), raising questions about the dividend's sustainability. While management achieved expense reductions and deployed $104.7 million into new investments, total debt concurrently increased to $911.6 million, a concern in the current rate climate.

Key Decisions for Investors

• Investors should closely monitor CCAP's non-accrual rates and NAV trajectory in subsequent quarters, as further deterioration could significantly impact returns and dividend sustainability.
• While the current discount to NAV may appear attractive for a long-term entry, the prevailing high interest rate environment and its negative impact on borrower health suggest a cautious approach is warranted, potentially waiting for signs of stabilization in credit quality.
• Given the weakened dividend coverage of approximately 107% and the risk of rising non-accruals, investors prioritizing stable income should critically assess the potential for a dividend adjustment and consider the ordinary income tax implications of CCAP's distributions, which may be best suited for tax-advantaged accounts.